Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Blocking CXXC5 speeds up diabetic wound healing by improving blood vessel growth and skin repair.

Blocking the JAK/STAT pathway may help reduce skin sensitivity in Xeroderma pigmentosum.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

10-20% of mouse Tregs have dual TCRs, suggesting potential functional benefits.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

The treatment was ineffective in humans.

Tcf3 helps cells move and heal wounds by controlling lipocalin 2.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

The new assay can help develop products for hair re-growth.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

CTHRC1 is essential for healing and preventing heart rupture after a heart attack.

Quercitrin may help treat Alzheimer's by boosting brain cell signaling without causing tumors.

IL-3 worsens lupus nephritis and blocking it improves kidney health.